Login / Signup
Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19.
Akiyoshi Takami
Published in:
International journal of hematology (2020)
Keyphrases
</>
low dose
coronavirus disease
sars cov
high dose
respiratory syndrome coronavirus